Searched over 200M research papers
10 papers analyzed
These studies suggest that calcium channel blockers are used to treat a range of conditions including hypertension, cardiovascular diseases, angina, and potentially glaucoma, with their effectiveness in reducing blood pressure and cardiovascular events being noted, though their safety and efficacy in some conditions require careful monitoring and further clarification.
20 papers analyzed
Calcium channel blockers (CCBs) are a class of medications that inhibit the entry of calcium ions into cells through voltage-gated calcium channels. These drugs are primarily used to treat various cardiovascular conditions, including hypertension, angina pectoris, and certain arrhythmias. Below are some examples of calcium channel blockers, categorized into their respective chemical families.
Dihydropyridines are a subclass of CCBs that primarily affect vascular smooth muscle, leading to vasodilation and reduced blood pressure. They are commonly used for treating hypertension and angina. Examples include:
Non-dihydropyridines primarily affect the heart, making them useful for treating arrhythmias and angina. They have more pronounced effects on cardiac muscle and conduction. Examples include:
CCBs are versatile drugs with a wide range of clinical applications beyond their primary use in cardiovascular diseases. They are also beneficial in conditions such as:
Calcium channel blockers are a diverse group of medications with significant therapeutic benefits in treating cardiovascular diseases and other conditions. Dihydropyridines like nifedipine, amlodipine, and nimodipine are primarily used for their vasodilatory effects, while non-dihydropyridines like verapamil and diltiazem are more focused on cardiac applications. Their versatility and efficacy make them a cornerstone in the management of various medical conditions.
Most relevant research papers on this topic